Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Arch Gynecol Obstet ; 310(1): 161-170, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38286817

RESUMO

PURPOSE: In a cohort of pregnant women using antihypertensive drugs, we compared exposure to antidepressants versus no exposure and the possible association with birth weight, APGAR scores, NICU admission, and maternal admission to an obstetrical intensive care unit (OHC). It was hypothesized that pregnant women with hypertensive disorders using antidepressants are at greater risk of complications. METHODS: A retrospective cohort study in a general teaching hospital in Zwolle, in the Middle-Northern part of The Netherlands. Finally, 58 pregnancies in the exposed group and 273 pregnancies in the reference group met all inclusion and exclusion criteria. We compared the neonate's birthweight between the exposed to antidepressants group and the reference group as the primary outcome. Secondary outcomes were the APGAR score at 1 and 5 min and obstetric high care (OHC) admission of the mother and neonatal intensive care unit (NICU) admission of the child. RESULTS: We found no differences in birth weight in neonates of mothers with hypertensive disorders and whether or not to use antidepressants. Besides a possible higher risk of admission to an OHC in women with hypertension-complicated pregnancies using antidepressants, we found no other maternal or neonatal risks in this population. CONCLUSION: We found no additional maternal or neonatal risks of using antidepressants prescribed to women with hypertension disorders during pregnancy.


Assuntos
Antidepressivos , Peso ao Nascer , Hipertensão Induzida pela Gravidez , Humanos , Feminino , Gravidez , Estudos Retrospectivos , Antidepressivos/efeitos adversos , Antidepressivos/uso terapêutico , Adulto , Recém-Nascido , Hipertensão Induzida pela Gravidez/tratamento farmacológico , Peso ao Nascer/efeitos dos fármacos , Índice de Apgar , Anti-Hipertensivos/efeitos adversos , Anti-Hipertensivos/uso terapêutico , Países Baixos/epidemiologia , Unidades de Terapia Intensiva Neonatal/estatística & dados numéricos , Complicações Cardiovasculares na Gravidez/tratamento farmacológico , Resultado da Gravidez/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...